Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.25p
   
  • Change Today:
    -0.75p
  • 52 Week High: 22.00
  • 52 Week Low: 7.25
  • Currency: UK Pounds
  • Shares Issued: 225.62m
  • Volume: 106,355
  • Market Cap: £20.87m

OBI Overview

Ondine Biomedical Inc. is a life sciences company, incorporated in Canada, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. Ondine has created a platform technology called antimicrobial photodynamic disinfection, or "photodisinfection", to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings.

1 Day Chart (08-12-2023)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2940.9% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 55.8 n/a
Pr/Book 3.1  
Latest F'cast
Revenue -75.2% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

OBI Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 1.79 (16.27) (23.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 2.57 (50.08) (63.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 0.64 (19.37) (10.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OBI Company Announcements

Result of Placing & Broker Option Update 05-Dec-2023 07:00 RNS
Close of Bookbuild 04-Dec-2023 13:28 RNS
Update. Re investor-led financing 01-Dec-2023 18:13 RNS

OBI ShareCast News

Ondine reports strong research findings from Can... 23-Oct-2023 ShareCast
Ondine announces expanded Canadian availability ... 13-Oct-2023 ShareCast
Ondine disinfection tech to be used at another C... 07-Aug-2023 ShareCast

Latest OBI Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

OBI Market Data

Currency UK Pounds
Share Price 9.25p
Change Today -0.75p
% Change -7.50 %
52 Week High 22.00
52 Week Low 7.25
Volume 106,355
Shares Issued 225.62m
Market Cap £20.87m

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.59% below the market average51.59% below the market average51.59% below the market average51.59% below the market average51.59% below the market average
71.93% below the sector average71.93% below the sector average71.93% below the sector average71.93% below the sector average71.93% below the sector average
Price Trend
87.93% below the market average87.93% below the market average87.93% below the market average87.93% below the market average87.93% below the market average
59.32% below the sector average59.32% below the sector average59.32% below the sector average59.32% below the sector average59.32% below the sector average
Income Not Available
Growth
46.66% below the market average46.66% below the market average46.66% below the market average46.66% below the market average46.66% below the market average
48.72% below the sector average48.72% below the sector average48.72% below the sector average48.72% below the sector average48.72% below the sector average

OBI Dividends

No dividends found

Trades for 08-Dec-2023

Time Volume / Share Price
15:02 10,558 @ 9.40p
14:50 20,000 @ 9.08p
13:50 3,000 @ 9.50p
13:41 27,419 @ 9.35p
11:27 5,126 @ 9.68p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page